Proton Pump Inhibitor Lawsuit | Esomeprazole | Lawsuits, Lawyer, Attorney | Side Effects : Fracture, Bone Fractures, Bone Breaks, Hip, Wrist, Spine, Hypomagnesemia
AstraZeneca’s Nexium | Takeda’s Prevacid | Prilosec OTC Procter & Gamble | Other PPI’s: Aciphex (rabeprazole) Protonix (pantoprazole) Dexilant (dexlansoprazole) Vimovo (combination of esomeprazole and the painkiller naproxen) Zegerid (combination of omeprazole and sodium bicarbonate) | Proton Pump Inhibitor Lawsuits : Boniva, Prilosec, Nexium, Prevacid, Protonix and Aciphex
A class of drugs referred to as Proton Pump Inhibitors have recently been linked to an increased risk of fractures. The Food and Drug Administration (FDA) has announced this risk of fractures are found to increase with long term use of these drugs often called PPI drugs. The labels of these drugs will be changed to alert consumers of this increased risk of fractures, mainly to the wrist, spine and hip.
If you or a loved one has sustained a fracture to the hip, wrist or spine while using PPI drugs, call us to discuss your potential claims and legal rights.
Proton pump inhibitor drugs include the following prescription medications:
And the following over the counter medications:
- Prilosec OTC
- Zegerid OTC
- Prevacid 24 Hour
Proton Pump Inhibitors are used to treat heartburn and gastroesophageal reflux disease (GERD). They are also prescribed to treat ulcers in the stomach and small intestine (stress gastritis), inflammation of the esophagus as well as Barrett’s esophagus, peptic ulcer disease and dyspepsia.
These label changes were prompted by a University of Pennsylvania study which found that people over 50 who take PPI drugs for more than one year have a 44 percent increased risk of a hip fracture. The increased risk for fracture occurred to a greater extent in men than in women. An increased risk of hip fractures was also found with the use of high dose PPIs as compared to regular doses of PPIs. Lastly, people who were users of PPIs for five years or longer were at the greatest risk of fractures. The study encompassed 145,000 people and was published in the May issue of the Archives of Internal Medicine.
PPI drugs have annual sales of 13.9 billion dollars. The PPI labels for the over the counter drugs indicate that they are only recommended for usage of 14 days. The label for these will be changed as well to warn of the increased risk of fractures.
For a free confidential evaluation of your potential claim involving your use of a PPI drug, please contact Alonso Krangle LLP by filling out our online form or calling 800-403-6191.